featured
Prevalence of BRAFV600 in Glioma and Use of BRAF Inhibitors for BRAFV600 Mutation–Positive Glioma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Neuro-Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Prevalence of BRAFV600 in glioma and use of BRAF Inhibitors in patients with BRAFV600 mutation-positive glioma: systematic review
Neuro-oncology 2022 Apr 01;24(4)528-540, LJ Andrews, ZA Thornton, SS Saincher, IY Yao, S Dawson, LA McGuinness, HE Jones, S Jefferies, SC Short, HY Cheng, A McAleenan, JPT Higgins, KM KurianFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Brain Cancer Center of Excellence
Visit our Brain Cancer Center of Excellence for additional, in-depth coverage.